Physician profile
Arif A Khalil
NPI 1619951290
$15,398.24
in general payments reported to CMS, 2019-2025
59 companies · $2,470 in 2025
The $2,470 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,486 · 2020: $1,476 · 2021: $2,890 · 2022: $1,827 · 2023: $3,354 · 2024: $1,896 · 2025: $2,470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,801 · Travel and Lodging: $838 · Entertainment: $60.14 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,801.43 |
| Travel and Lodging | $838.43 |
| Entertainment | $60.14 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,780.31 | 2019-2025 | |
| Medtronic, INC. | $1,539.14 | 2021-2025 | Turbohawk, Corevalve Evolut R, Abre |
| Janssen Pharmaceuticals, INC | $1,336.02 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $1,176.26 | 2019-2025 | Farxiga, Brilinta, Lokelma |
| Amgen INC. | $950.40 | 2019-2025 | Repatha, Repatha |
| Endologix LLC | $569.82 | 2021-2025 | Alto Abdominal Stent Graft System |
| Merck Sharp & Dohme LLC | $504.97 | 2021-2024 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $465.87 | 2020-2025 | Jardiance |
| Medtronic Vascular, INC. | $419.16 | 2019-2020 | |
| Pfizer INC. | $414.72 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $399.97 | 2019-2025 | Lifevest |
| Chiesi USA, INC. | $392.15 | 2019-2025 | Cleviprex, Kengreal |
| Esperion Therapeutics, INC. | $355.27 | 2020-2025 | Nexletol |
| Boston Scientific Corporation | $339.83 | 2019-2025 | Rotapro, General - Crm_crm |
| Bayer Healthcare Pharmaceuticals INC. | $335.81 | 2022-2025 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $320.31 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Alnylam Pharmaceuticals INC. | $279.79 | 2020-2025 | Amvuttra, Onpattro |
| Livanova USA, INC. | $256.30 | 2022 | |
| Cardiovascular Systems INC. | $250.17 | 2019-2022 | |
| Abbott Laboratories | $241.21 | 2021-2025 | Cardiomems, Perclose Prostyle, Diamondback Peripheral |
| Abiomed | $227.59 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $218.80 | 2019-2021 | |
| Acist Medical Systems, INC. | $193.71 | 2023 | |
| Inspire Medical Systems, INC. | $192.39 | 2023-2024 | Inspire |
| Atricure, INC. | $189.32 | 2023-2024 | |
| Shockwave Medical, INC | $176.55 | 2025 | |
| Penumbra, INC. | $175.81 | 2023-2025 | Penumbra System, Indigo System |
| Bridgebio Pharma, INC. | $168.21 | 2025 | Attruby |
| E.R. Squibb & Sons, L.L.C. | $143.54 | 2020-2025 | Camzyos, Eliquis |
| Vifor Pharma, INC. | $139.05 | 2019-2021 | |
| Novo Nordisk INC | $118.96 | 2023-2025 | Wegovy, Ozempic |
| Scpharmaceuticals INC. | $113.62 | 2023-2025 | |
| Opsens INC. | $108.86 | 2022-2023 | Optowire |
| Cook Medical LLC | $100.93 | 2019-2023 | Cook |
| Surmodics, INC. | $98.76 | 2025 | Pounce LP Thrombectomy, Pounce Thrombectomy, Pounce Thrombectomy System |
| Lexicon Pharmaceuticals, INC. | $57.59 | 2023-2024 | Inpefa |
| Heartflow, INC. | $57.39 | 2024-2025 | |
| Astellas Pharma US INC | $54.44 | 2019-2020 | |
| Amarin Pharma, INC. | $47.89 | 2020-2021 | |
| Thrombolex, INC. | $44.91 | 2025 | Bashir Endovascular Catheter |
| Medline Industries LP | $40.20 | 2022-2025 | |
| Lantheus Medical Imaging, INC. | $37.98 | 2020-2021 | |
| Itamar Medical INC | $35.02 | 2025 | Watchpatone |
| Edwards Lifesciences Corporation | $34.09 | 2025 | Sapien 3 Ultra Resilia |
| Cordis US Corp. | $33.25 | 2023-2024 | Mynxgrip |
| Vanda Pharmaceuticals INC. | $32.19 | 2024 | Hetlioz, Fanapt |
| Bard Peripheral Vascular, INC. | $32.16 | 2021 | |
| Ekos Corporation | $21.59 | 2019 | |
| Cardiva Medical, INC. | $19.81 | 2023 | Cardiva Vascade 5f Vcs |
| Angiodynamics, INC. | $18.74 | 2022 | |
| Stryker Corporation | $17.43 | 2025 | Artix Mt |
| La Jolla Pharmaceutical Company | $17.09 | 2020 | |
| Glaxosmithkline, LLC. | $16.37 | 2025 | Shingrix |
| Philips North America LLC | $15.66 | 2022 | |
| Amryt Pharma Holdings LTD | $15.37 | 2021 | |
| Cagent Vascular INC | $15.00 | 2025 | Serrantor |
| Impulse Dynamics (USA) INC. | $14.68 | 2023 | Optimizer |
| Daiichi Sankyo INC. | $13.11 | 2022 | |
| Cvrx, INC. | $12.70 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arif Khalil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.